|
Re: New figures (from one cancer center) of incidence of cardiomyopathy from hercepti
they did differentiate the rate of cardiomyopathy in those treated adjuvantly (19.5%) vs all those treated for ie those treated adjuvantly AND those treated for metastatic disease (33% of ALL patients treated).
|